Long-term effectiveness of lithium in bipolar disorder: A multicenter investigation of patients with typical and atypical features

Journal of Clinical Psychiatry

Volumn 69, Issue 12, 2008, Pages 1860-1868

  Berghöfer, Anne ^a,j   Alda, Martin ^b,j   Adli, Mazda ^a,j   Baethge, Christopher ^c,j   Bauer, Michael ^d,j   Bschor, Tom ^e,j   Glenn, Tasha ^f,j   Grof, Paul ^g,h,j   Müller Oerlinghausen, Bruno ^a,j   Rybakowski, Janusz ^i,j   Suwalska, Alexandra ^i,j   Pfennig, Andrea ^d,j  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DALHOUSIE UNIVERSITY   (Canada)

^c UNIVERSITY OF COLOGNE   (Germany)

^d UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^e Jewish Hospital Berlin   (Germany)

^f ChronoRecord Association Inc   (United States)

^g Mood Disorders Center of Ottawa   (Canada)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^j International Group for the Study of Lithium Treated Patients   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MANIA; MORBIDITY; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANTIMANIC AGENTS; BIPOLAR DISORDER; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LITHIUM CARBONATE; LONG-TERM CARE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; YOUNG ADULT;

EID: 60349124065     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n1203     Document Type: Article

References (56)

1. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Bipolar Disorder (revision). Am J Psychiatry 2002 Apr;159(suppl 4):1-50
2. Grunze H, Kasper S, Goodwin G, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J Biol Psychiatry 2004;5:120-135
3. Yatham LN, Kennedy SH, O'Donovan C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord 2005;7(suppl 3):5-69
4. Crossley NA, Müller-Oerlinghausen B, Glenn T, et al. The position of lithium in international and national guidelines for the treatment of mood disorders. In: Bauer M, Grof P, Müller-Oerlinghausen B, eds. Lithium in Neuropsychiatry: The Comprehensive Guide. Abingdon, England: Informa Healthcare; 2006:33-42
5. Suppes T, Dennehy EB, Hirschfeld RM, et al. Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder. The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry 2005 Jul;66(7):870-886
6. Burgess S, Geddes J, Hawton K, et al. Lithium for maintenance treatment of mood disorders Cochrane Database Syst Rev. 2001;3:CD003013
7. Geddes JR, Goodwin GM. Maintenance treatment with lithium in bipolar disorder. In: Bauer M, Grof P, Müller-Oerlinghausen, eds. Lithium in Neuropsychiatry: The Comprehensive Guide. Abingdon, England: Informa Healthcare; 2006:73-85
8. Surtees PG, Barkley C. Future imperfect: the long-term outcome of depression. Br J Psychiatry 1994;164:327-341
9. Harrow M, Goldberg JF, Grossman LS, et al. Outcome in manic disorders. Arch Gen Psychiatry 1990;47:665-671
10. Keller MB, Lavori PW, Coryell W, et al. Bipolar I: a five-year prospective follow-up. J Nerv Ment Dis 1993;181:238-245
11. Post RM, Leverich GS, Pazzaglia PJ, et al. Lithium tolerance and discontinuation as pathways to refractoriness. In: Birch NJ, Padgham C, Hughes MS, eds. Lithium in Medicine and Biology. Carnforth, England: Marius Press; 1993:71-84
12. Maj M, Pirozzi R, Kemali D. Long-term outcome of lithium prophylaxis in patients initially classified as complete responders. Psychopharmacology 1989;98:535-538
13. Grof P. Has the effectiveness of lithium changed? impact of the variety of lithium's effects. Neuropsychopharmacology 1998 Sep;19(3):183-188
14. Grof P, Alda M, Ahrens B. Clinical course of affective disorders: were Emil Kraepelin and Jules Angst wrong? Psychopathology 1995;28(suppl 1):73-80
15. Goodwin GM. Prophylaxis of bipolar disorder: how and who should we treat in the long term? Eur Neuropsychopharmacol 1999 Aug;9(suppl 4):S125-S129
16. Deshauer D, Fergusson D, Duffy A, et al. Re-evaluation of randomised control trials of lithium monotherapy: a cohort effect. Bipolar Disord 2005;7:382-387
17. Berky M, Wolf C, Kovacs G. Carbamazepine versus lithium in bipolar affective disorders. Eur Arch Psychiatr Clin Neurosci 1998;248:119
18. Greil W, Kleindienst N, Erazo N, et al. Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. J Clin Psychopharmacol 1998;18:455-460
19. Greil W, Kleindienst N. The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder. Int Clin Psychopharmacol 1999;14:277-281
20. Bowden CL. Clinical correlates of therapeutic response in bipolar disorder. J Affect Disord 2001;67:257-265
21. Hartong EG, Moleman P, Hoogduin CA, et al. Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients. J Clin Psychiatry 2003;64:144-151
22. Aagaard J, Vestergaard P. Predictors of outcome in prophylactic lithium treatment: a 2-year prospective study. J Affect Disord 1990;18:259-266
23. Calabrese JR, Fatemi SH, Kujawa M, et al. Predictors of response to mood stabilizers. J Clin Psychopharmacol 1996 Apr;16(2 suppl 1):24S-31S
24. Maj M, Del Vecchio M, Starace F, et al. Prediction of affective psychoses response to lithium prophylaxis. Acta Psychiatr Scand 1984;69:37-44
25. Maj M. Clinical prediction of response to lithium prophylaxis in bipolar patients: a critical update. Lithium 1992;3:15-21
26. Nilsson A, Axelsson R. Psychopathology during long-term lithium treatment of patients with major affective disorders: a prospective study. Acta Psychiatr Scand 1989;80:375-388
27. Grof P, Hux M, Grof E, et al. Prediction of response to stabilizing lithium treatment. Pharmacopsychiatria 1983 Nov;16(6):195-200
28. Grof P, Alda M, Grof E, et al. The challenge of predicting response to stabilizing lithium treatment: the importance of patient selection. Br J Psychiatry Suppl 1993 Sep;(21):16-19
29. World Health Organization. International Classification of Diseases, 8th Revision. Geneva, Switzerland: World Health Organization; 1969
30. World Health Organization. International Classification of Diseases, 9th Revision. Geneva, Switzerland: World Health Organization; 1979
31. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
32. Müller-Oerlinghausen B, Wolf T, Ahrens B, et al. Mortality during initial and during later lithium treatment: a collaborative study by the International Group for the Study of Lithium-treated Patients (IGSLI). Acta Psychiatr Scand 1994;90:295-297
33. Bech P, Rafaelsen OJ. The use of rating scales exemplified by a comparison of the Hamilton and the Bech-Rafaelsen Melancholia Scale. Acta Psychiatr Scand Suppl 1980;285:128-131
34. Bech P, Rafaelsen OJ, Kramp P, et al. The mania rating scale: scale construction and inter-observer agreement. Neuropharmacology 1978;17:430-431
35. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
36. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429-435
37. Coppen A, Abou-Saleh MT. Plasma folate and affective morbidity during long-term lithium therapy. Br J Psychiatry 1982;141:87-89
38. Hathaway R, McKinley JC. Minnesota Multiphasic Personality Inventory: Manual, Revised. New York, NY: Psychological Corporation New York; 1951
39. Grof P, Lane J, MacCrimmon D, et al. Clinical and laboratory correlates of the response to long-term lithium treatment. In: Stromgren E, Schou M, eds. Origin, Prevention and Treatment of Affective Disorders. London, England: Academic Press; 1979:27-40
40. Lane J, Grof P, Daigle L, et al. The Minnesota multiphasic personality inventory in the prediction of response to lithium stabilization. In: Dufour H, Pringuey D, Milech T, eds. The Prediction of Lithium Response. Marseille, France: Colloque de Marseille, L'Imprimerie Choler; 1983: 215-220
41. Demidenko N, Grof P, Alda M, et al. MMPI as a measure of subthreshold and residual psychopathology among the offspring of lithium responsive and non-responsive bipolar parents. Bipolar Disord 2004 Aug;6(4):323-328
42. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov BN, ed. Proceedings of the Second International Symposium on Information Theory. Budapest, Hungary: Akademiai Kiado; 1973:267-281
43. Bowden CL, Calabrese JR, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003;60:392-400
44. Tohen M, Greil W, Calabrese JR, et al. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am J Psychiatry 2005;162:1281-1290
45. Viguera AC, Baldessarini RJ, Tondo L. Response to lithium treatment in bipolar disorders: comparison of women and men. Bipolar Disord 2001;3:245-252
46. Berghöfer A, Kossmann B, Müller-Oerlinghausen B. Course of illness and pattern of recurrences in patients with affective disorders during long-term lithium prophylaxis: a retrospective analysis over 15 years. Acta Psychiatr Scand 1996;93:349-354
47. Goldberg JF, Harrow M, Grossman LS. Course and outcome in bipolar affective disorder: a longitudinal follow-up study. Am J Psychiatry 1995;152:379-384
48. Vestergaard P, Schou M. Prospective studies on a lithium cohort, 1: general features. Acta Psychiatr Scand 1988;78:421-426
49. Kraepelin E. Manic Depressive Insanity and Paranoia. Edinburgh, UK: ES Livingstone; 1921
50. Berghöfer A, Müller-Oerlinghausen B. Is there a loss of efficacy of lithium in patients treated for over 20 years? Neuropsychobiology 2000;42(suppl 1):46-49
51. Kleindienst N, Greil W, Rüger B, et al. The prophylactic efficacy of lithium - transient or persistent? Eur Arch Psychiatr Clin Neurosci 1999;249:144-149
52. Maj M. The effect of lithium in bipolar disorder: a review of recent research evidence. Bipolar Disord 2003;5:180-188
53. Franchini L, Zanardi R, Smeraldi E, et al. Early onset of lithium prophylaxis as a predictor of good long-term outcome. Eur Arch Psychiatry Clin Neurosci 1999;249:227-230
54. Baethge C, Smolka MN, Gruschka P, et al. Does prophylaxis delay in bipolar disorder influence outcome? results from a long-term study of 147 patients. Acta Psychiatr Scand 2003 Apr;107(4):260-267
55. Baethge C, Tondo L, Bratti IM, et al. Prophylaxis-latency and outcome in bipolar disorders. Can J Psychiatry 2003;48:449-457
56. Baldessarini RJ, Tondo L, Hennen J. Treatment-latency and previous episodes: relationships to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders. Bipolar Disord 2003;5:169-179